Procter & Gamble Hygiene and Health Care Limited (NSE:PGHH) — Stock Price
Procter & Gamble Hygiene and Health Care Limited (NSE:PGHH) is currently trading at Rs8482.00 INR, down 0.18% today. Over the past 52 weeks, shares have ranged between Rs8477.00 and Rs14380.00. This page tracks Procter & Gamble Hygiene and Health Care Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PGHH company net worth.
Procter & Gamble Hygiene and Health Care Limited (PGHH) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Procter & Gamble Hygiene and Health Care Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Procter & Gamble Hygiene and Health Care Limited Income Statement — Revenue, Profit & Earnings by Year
Procter & Gamble Hygiene and Health Care Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Rs44.99 Billion | Rs41.92 Billion | Rs39.05 Billion | Rs37.92 Billion | Rs35.70 Billion |
| Cost of Revenue | Rs19.51 Billion | Rs18.39 Billion | Rs18.81 Billion | Rs17.62 Billion | Rs13.29 Billion |
| Gross Profit | Rs25.48 Billion | Rs23.52 Billion | Rs20.24 Billion | Rs20.30 Billion | Rs22.42 Billion |
| Research & Development | — | — | — | — | — |
| SG&A | Rs7.46 Billion | Rs436.30 Million | Rs439.50 Million | Rs555.80 Million | Rs490.30 Million |
| Total Operating Expenses | Rs14.30 Billion | Rs14.04 Billion | Rs12.00 Billion | Rs12.36 Billion | Rs13.84 Billion |
| Operating Income | Rs11.19 Billion | Rs9.49 Billion | Rs8.24 Billion | Rs7.94 Billion | Rs8.58 Billion |
| EBITDA | Rs12.11 Billion | Rs10.23 Billion | Rs9.09 Billion | Rs8.54 Billion | Rs9.24 Billion |
| EBIT | Rs11.69 Billion | Rs9.66 Billion | Rs8.51 Billion | Rs8.01 Billion | Rs8.76 Billion |
| Interest Expense | Rs2.40 Million | Rs267.80 Million | Rs113.80 Million | Rs111.90 Million | Rs61.10 Million |
| Income Before Tax | Rs11.50 Billion | Rs9.39 Billion | Rs8.39 Billion | Rs7.90 Billion | Rs8.70 Billion |
| Income Tax Expense | Rs3.01 Billion | Rs2.64 Billion | Rs1.61 Billion | Rs2.14 Billion | Rs2.18 Billion |
| Net Income | Rs8.49 Billion | Rs6.75 Billion | Rs6.78 Billion | Rs5.76 Billion | Rs6.52 Billion |
Procter & Gamble Hygiene and Health Care Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Procter & Gamble Hygiene and Health Care Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Rs17.55 Billion | Rs18.59 Billion | Rs21.37 Billion | Rs16.81 Billion | Rs16.33 Billion |
| Total Current Assets | Rs11.07 Billion | Rs12.00 Billion | Rs14.96 Billion | Rs11.34 Billion | Rs11.17 Billion |
| Cash & Equivalents | Rs4.10 Billion | Rs5.15 Billion | Rs8.82 Billion | Rs5.99 Billion | Rs6.12 Billion |
| Short-term Investments | Rs494.60 Million | Rs1.04 Billion | Rs469.30 Million | Rs142.70 Million | Rs25.31 Billion |
| Net Receivables | Rs3.09 Billion | Rs3.34 Billion | Rs2.52 Billion | Rs2.18 Billion | Rs1.73 Billion |
| Inventory | Rs2.21 Billion | Rs2.26 Billion | Rs2.20 Billion | Rs2.34 Billion | Rs2.49 Billion |
| Property, Plant & Equipment | Rs1.72 Billion | Rs1.67 Billion | Rs1.93 Billion | Rs2.08 Billion | Rs2.21 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | Rs10.18 Billion | Rs10.84 Billion | Rs11.91 Billion | Rs9.44 Billion | Rs9.18 Billion |
| Total Current Liabilities | Rs9.01 Billion | Rs9.81 Billion | Rs10.85 Billion | Rs8.58 Billion | Rs8.35 Billion |
| Long-term Debt | — | — | — | — | Rs1.80 Million |
| Net Debt | Rs-4.78 Billion | Rs-5.71 Billion | Rs-9.60 Billion | Rs-6.20 Billion | Rs-6.44 Billion |
| Total Stockholder Equity | Rs7.37 Billion | Rs7.75 Billion | Rs9.46 Billion | Rs7.38 Billion | Rs7.14 Billion |
| Retained Earnings | Rs5.81 Billion | Rs6.10 Billion | Rs4.80 Billion | Rs2.80 Billion | Rs2.67 Billion |
Procter & Gamble Hygiene and Health Care Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Procter & Gamble Hygiene and Health Care Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs6.18 Billion | Rs4.71 Billion | Rs8.26 Billion | Rs5.73 Billion | Rs8.63 Billion |
| Capital Expenditures | Rs550.30 Million | Rs446.80 Million | Rs444.40 Million | Rs498.00 Million | Rs316.00 Million |
| Free Cash Flow | Rs5.63 Billion | Rs4.26 Billion | Rs7.81 Billion | Rs5.23 Billion | Rs8.32 Billion |
| Investing Cash Flow | Rs-586.30 Million | Rs10.60 Million | Rs-99.10 Million | Rs-268.50 Million | Rs69.40 Million |
| Financing Cash Flow | Rs-6.66 Billion | Rs-8.62 Billion | Rs-4.77 Billion | Rs-5.69 Billion | Rs-11.06 Billion |
| Dividends Paid | Rs6.65 Billion | Rs8.60 Billion | Rs4.71 Billion | Rs5.68 Billion | Rs11.04 Billion |
| Stock-Based Compensation | — | Rs85.00 Million | Rs84.80 Million | Rs101.50 Million | Rs69.50 Million |
| Depreciation | Rs425.87 Million | Rs565.00 Million | Rs583.60 Million | Rs528.80 Million | Rs476.60 Million |
| Change in Cash | Rs-4.97 Billion | Rs-3.90 Billion | Rs3.39 Billion | Rs-226.90 Million | Rs-2.36 Billion |
Procter & Gamble Hygiene and Health Care Limited Earnings History — EPS Actual vs. Analyst Estimates
Track Procter & Gamble Hygiene and Health Care Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 28, 2026 | 47.17 | 69.30 | -31.93% |
| Jan 30, 2026 | 92.87 | 77.90 | +19.22% |
| Nov 06, 2025 | 64.65 | 72.70 | -11.07% |
| Aug 28, 2025 | — | 41.00 | — |
| May 27, 2025 | 48.09 | 64.00 | -24.86% |
| Feb 11, 2025 | 82.74 | 82.60 | +0.17% |
| Oct 30, 2024 | 65.28 | 73.80 | -11.54% |
| Aug 28, 2024 | 24.97 | 44.20 | -43.51% |